Implantable Analyte Sensor Biointerface Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional analyte sensors for diabetes management are limited by their short-term nature, discomfort, and inconvenience, leading to inadequate patient monitoring and delayed detection of hyper- or hypoglycemic conditions.
Innovation Solution
An implantable analyte sensor with a sensing region and a non-sensing region, utilizing biointerface materials to promote vascularized tissue ingrowth and anchoring, enabling long-term implantation and continuous glucose monitoring with RF transmission capabilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If conventional transcutaneous or partially implantable analyte sensors are used, then short-term monitoring is provided, but patient comfort is compromised and continuous care cannot be achieved
Solution Approach 1:
The sensor is divided into distinct functional regions: a sensing region with first biointerface material for analyte measurement, and a non-sensing region with second biointerface material for anchoring. This segmentation allows each region to perform its specialized function optimally while working together as an integrated system for long-term implantation.
Solution Approach 2:
Different biointerface materials with distinct properties are applied to different regions of the sensor. The first biointerface material has properties optimized for analyte transport and sensing, while the second biointerface material has properties optimized for tissue ingrowth and anchoring. This local differentiation resolves the contradiction by providing region-specific functionality.
2Duration of action of stationary object
If short-term analyte sensors are used, then continuous monitoring is not provided, but device complexity is reduced
Solution Approach 1:
The sensor body serves multiple functions: it houses the sensing region for analyte detection, provides structural support for electronic components, and interfaces with tissue through biointerface materials. The first and second biointerface materials work together to provide both analyte access and mechanical anchoring, reducing the need for separate components.
Solution Approach 2:
The sensing region and anchoring region are merged into a single integrated sensor body, with both regions utilizing biointerface materials that promote tissue integration. This combination allows the sensor to achieve long-term implantation capability while maintaining a relatively simple overall structure.
3Reliability
If barrier cell layer formation is allowed to occur, then tissue encapsulation is achieved, but analyte transport to the sensing region is blocked
Solution Approach 1:
The first biointerface material creates a localized environment that promotes vascularized tissue ingrowth while preventing the formation of a continuous barrier cell layer at the sensing interface. This local control allows analyte transport to proceed efficiently while still achieving stable tissue integration elsewhere on the sensor.
Solution Approach 2:
The first biointerface material acts as an intermediary between the sensing region and the surrounding tissue, facilitating analyte transport while modulating the tissue response to prevent barrier layer formation that would block analyte access to the sensing elements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution provides improved patient convenience and care by enabling continuous, accurate glucose monitoring, reducing the risk of dangerous glycemic events through long-term implantation and reliable data transmission.
Implementation Method 1
a first biointerface material adjacent to the sensing region, wherein the first biointerface material includes a porous architecture that promotes vascularized tissue ingrowth and interferes with barrier cell layer formation, for allowing analyte transport to the sensing region in vivo
Implementation Method 2
a second biointerface material adjacent to at least a portion of the non-sensing region, wherein the second biointerface material includes a porous architecture that promotes tissue ingrowth for anchoring the sensor in vivo
Implementation Method 3
a first biointerface material adjacent to the sensing region, wherein the first biointerface material includes a porous architecture that promotes vascularized tissue ingrowth and interferes with barrier cell layer formation, for allowing analyte transport to the sensing region in vivo
Data Source
AI summary
An implantable analyte sensor including a sensing region for measuring the analyte and a non-sensing region for immobilizing the sensor body in the host. The sensor is implanted in a precisely dimensioned pocket to stabilize the analyte sensor in vivo and enable measurement of the concentration of the analyte in the host before and after formation of a foreign body capsule around the sensor. The sensor further provides a transmitter for RF transmission through the sensor body, electronic circuitry, and a power source optimized for long-term use in the miniaturized sensor body.